Zhang Yi, Shen Yu, Wan Zhiqiang, Tao Song, Liu Yakui, Wang Shuanhu
Department of Gastrointestinal Surgery, First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233030, China.
Graduate School of Bengbu Medical University, Bengbu, Anhui 233030, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Apr 20;45(4):853-861. doi: 10.12122/j.issn.1673-4254.2025.04.21.
To investigate the expression of CDKN3 in gastric cancer and its impact on prognosis of gastric cancer patients.
We analyzed CDKN3 expression in clinical specimens from 114 gastric cancer patients and assessed its association with 5-year postoperative survival of the patients. GO and KEGG enrichment analyses were used to predict the biological function and possible mechanism of CDKN3. The effects of lentivirus-mediated CDKN3 knockdown on biological behaviors of gastric cancer cells were evaluated using Transwell assay, CCK-8 assay, TUNEL staining, flow cytometry, and Western blotting.
CDKN3 expression was significantly higher in gastric cancer tissues than in the adjacent tissues with significant correlations with CEA level, CA19-9 level, and T and N staging (<0.05). High CDKN3 expression was an independent risk factor affecting 5-year postoperative survival of the patients and predictive for long-term prognosis (<0.01). Enrichment analyses suggested a probable association of CDKN3 with apoptosis. In MGC-803 cells, CDKN3 knockdown significantly lowered migration and invasion capacities of the cells, while CDKN3 overexpression produced the opposite effects. TUNEL staining revealed a significantly lower level of cell apoptosis in gastric cancer tissues than in adjacent tissues (<0.01). CDKN3 knockdown obviously inhibited proliferation and increased apoptosis of MGC-803 cells. CDKN3 overexpression down-regulated the expressions of p53, p21 and Bax and up-regulated the expressions of p-p65 and Bcl-2.
CDKN3 is highly expressed in gastric cancer tissues and affects patient prognosis. CDKN3 overexpression promotes proliferation, invasion and migration and suppressed apoptosis of gastric cancer cells possibly through the p53/NF-κB signaling pathway.
研究细胞周期蛋白依赖性激酶3(CDKN3)在胃癌中的表达及其对胃癌患者预后的影响。
分析114例胃癌患者临床标本中CDKN3的表达情况,并评估其与患者术后5年生存率的相关性。采用基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析预测CDKN3的生物学功能及可能机制。运用Transwell实验、CCK-8实验、TUNEL染色、流式细胞术和蛋白质免疫印迹法评估慢病毒介导的CDKN3基因敲低对胃癌细胞生物学行为的影响。
CDKN3在胃癌组织中的表达显著高于癌旁组织,且与癌胚抗原(CEA)水平、糖类抗原19-9(CA19-9)水平以及肿瘤分期(T分期和N分期)显著相关(P<0.05)。CDKN3高表达是影响患者术后5年生存的独立危险因素,对长期预后具有预测价值(P<0.01)。富集分析提示CDKN3可能与细胞凋亡相关。在MGC-803细胞中,敲低CDKN3可显著降低细胞的迁移和侵袭能力,而过表达CDKN3则产生相反作用。TUNEL染色显示,胃癌组织中的细胞凋亡水平显著低于癌旁组织(P<0.01)。敲低CDKN3明显抑制MGC-803细胞增殖并增加其凋亡。过表达CDKN3可下调p53、p21和Bax的表达,上调磷酸化p65(p-p65)和Bcl-2的表达。
CDKN3在胃癌组织中高表达并影响患者预后。CDKN3过表达可能通过p53/核因子κB(NF-κB)信号通路促进胃癌细胞增殖、侵袭和迁移,并抑制其凋亡。